Armillaridin induces autophagy-associated cell death in human chronic myelogenous leukemia K562 cells

In conclusion, AM is capable of inhibiting growth and inducing autophagy-associated cell death in K562 cells, but not in normal monocytes. It may have potential to be developed as a novel therapeutic agent against leukemia.
Source: Tumor Biology - Category: Cancer & Oncology Source Type: research